Expression of S100 protein family members in the pathogenesis of bladder tumors

Anticancer Research

Volumn 27, Issue 5 A, 2007, Pages 3051-3058

  Yao, Ruisheng ^a   Lopez Beltran, Antonio ^b   Maclennan, Gregory T ^c   Montironi, Rodolfo ^d   Eble, John N ^e   Cheng, Liang ^e  

^a USA   (United States)

^b UNIVERSITY OF CÓRDOBA   (Spain)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

^d UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^e INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Biomarkers; Bladder; Neoplasia; Proteomics; S100 proteins; Transitional cell carcinoma; Urinary tract; Urothelial carcinoma

Indexed keywords

CALVASCULIN; N BUTYL N (4 HYDROXYBUTYL)NITROSAMINE; PROTEIN S 100; PROTEIN S 100A14; PROTEIN S 100A15; PROTEIN S 100A16; PROTEIN S 100A2; PROTEIN S 100A3; PROTEIN S 100A5; PROTEIN S 100A8; PROTEIN S 100A9; PROTEIN S100B; PSORIASIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLADDER CANCER; BLADDER TUMOR; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; UROTHELIUM;

ANIMALS; CARCINOMA, TRANSITIONAL CELL; FEMALE; GENE EXPRESSION; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION; RATS; RATS, INBRED F344; RNA, MESSENGER; S100 PROTEINS; URINARY BLADDER NEOPLASMS;

EID: 35348953175     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C and Thun MJ: Cancer statistics, 2006. CA Cancer J Clin 56: 106-130, 2006.
2. Ghoneim MA, el-Mekresh MM, el-Baz MA, el-Attar IA and Ashamallah A: Radical cystectomy for carcinoma of the bladder: critical evaluation of the results in 1,026 cases. J Urol 158: 393-399, 1997.
3. Droller MJ: Bladder cancer: state-of-the-art care. CA Cancer J Clin 48: 269-284, 1998.
4. Cheng L, Weaver AL, Leibovich BC, Ramnani DM, Neumann RM, Sherer BG, Nehra A, Zincke H and Bostwick DG: Predicting the survival of bladder carcinoma patients treated with radical cystectomy. Cancer 88: 2326-2332, 2000.
5. Droller MJ: Markers in bladder cancer - issues to consider. J Urol 160: 2009-2010, 1998.
6. Grubbs CJ, Lubet RA, Koki AT, Leahy KM, Masferrer JL, Steele VE, Kelloff GJ, Hill DL and Seibert K: Celecoxib inhibits N-butyl-N-(4- hydroxybutyl)-nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 rats. Cancer Res 60: 5599-5602, 2000.
7. Grubbs CJ, Moon RC, Squire RA, Farrow GM, Stinson SF, Goodman DG, Brown CC and Sporn MB: 13-cis-Retinoic acid: inhibition of bladder carcinogenesis induced in rats by N-butyl-N-(4-hydroxybutyl) nitrosamine. Science 198: 743-744, 1977.
8. Lubet RA, Huebner K, Fong LY, Altieri DC, Steele VE, Kopelovich L, Kavanaugh C, Juliana MM, Soong SJ and Grubbs CJ: 4-Hydroxybutyl(butyl) nitrosamine-induced urinary bladder cancers in mice: characterization of FHIT and survivin expression and chemopreventive effects of indomethacin. Carcinogenesis 26: 571-578, 2005.
9. Iliopoulos D, Guler G, Han SY, Johnston D, Druck T, McCorkell KA, Palazzo J, McCue PA, Baffa R and Huebner K: Fragile genes as biomarkers: epigenetic control of WWOX and FHIT in lung, breast and bladder cancer. Oncogene 24: 1625-1633, 2005.
10. Marenholz I, Heizmann CW and Fritz G: S100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature). Biochem Biophys Res Commun 322: 1111-1122, 2004.
11. Heizmann CW, Fritz G and Schafer BW: S100 proteins: structure, functions and pathology. Front Biosci 7: 1356-1368, 2002.
12. Davies BR, O'Donnell M, Durkan GC, Rudland PS, Barraclough R, Neal DE and Mellon JK: Expression of S100A4 protein is associated with metastasis and reduced survival in human bladder cancer. J Pathol 196: 292-299, 2002.
13. Cross SS, Hamdy FC, Deloulme JC and Rehman I: Expression of S100 proteins in normal human tissues and common cancers using tissue microarrays: S100A6, S100A8, S100A9 and S100A11 are all overexpressed in common cancers. Histopathology 46: 256-269, 2005.
14. Celis JE, Rasmussen HH, Vorum H, Madsen P, Honore B, Wolf H and Orntoft TF: Bladder squamous cell carcinomas express psoriasin and externalize it to the urine. J Urol 155: 2105-2112, 1996.
15. Memon AA, Sorensen BS, Meldgaard P, Fokdal L, Thykjaer T and Nexo E: Down-regulation of S100C is associated with bladder cancer progression and poor survival. Clin Cancer Res 11: 606-611, 2005.
16. 2+-binding S100 proteins. Histol Histopathol 16: 707-712, 2001.
17. Jenkinson SR, Barraclough R, West CR and Rudland PS: S100A4 regulates cell motility and invasion in an in vitro model for breast cancer metastasis. Br J Cancer 90: 253-262, 2004.
18. Hsieh HL, Schafer BW, Sasaki N and Heizmann CW: Expression analysis of S100 proteins and RAGE in human tumors using tissue microarrays. Biochem Biophys Res Commun 307: 375-381, 2003.
19. Emberley ED, Niu Y, Leygue E, Tomes L, Gietz RD, Murphy LC and Watson PH: Psoriasin interacts with Jab1 and influences breast cancer progression. Cancer Res 63: 1954-1961, 2003.
20. Nagy N, Brenner C, Markadieu N, Chaboteaux C, Camby I, Schafer BW, Pochet R, Heizmann CW, Salmon I, Kiss R et al: S100A2, a putative tumor suppressor gene, regulates in vitro squamous cell carcinoma migration. Lab Invest 81: 599-612, 2001.
21. Gupta S, Hussain T, MacLennan GT, Fu P, Patel J and Mukhtar H: Differential expression of S100A2 and S100A4 during progression of human prostate adenocarcinoma. J Clin Oncol 21: 106-112, 2003.
22. 2+-relevant and differentiation- associated genes downregulated in esophageal squamous cell carcinoma using cDNA microarray. Oncogene 23: 1291-1299, 2004.
23. Qin SL, Chen XJ, Xu X, Shou JZ, Bi XG, Ji L, Han YL, Cai Y, Wei F, Ma JH et al: Detection of chromosomal alterations in bladder transitional cell carcinomas from Northern China by comparative genomic hybridization. Cancer Lett 238: 230-239, 2006.
24. Richter J, Jiang F, Gorog JP, Sartorius G, Egenter C, Gasser TC, Moch H, Mihatsch MJ and Sauter G: Marked genetic differences between stage pTa and stage pT1 papillary bladder cancer detected by comparative genomic hybridization. Cancer Res 57: 2860-2864, 1997.
25. Simon R, Burger H, Brinkschmidt C, Bocker W, Hertle L and Terpe HJ: Chromosomal aberrations associated with invasion in papillary superficial bladder cancer. J Pathol 185: 345-351, 1998.
26. Levett D, Flecknell PA, Rudland PS, Barraclough R, Neal DE, Mellon JK and Davies BR: Transfection of S100A4 produces metastatic variants of an orthotopic model of bladder cancer. Am J Pathol 160: 693-700, 2002.
27. Agerbaek M, Alsner J, Marcussen N, Lundbeck F and Von Der Maase H: Focal S100A4 protein expression is an independent predictor of development of metastatic disease in cystectomized bladder cancer patients. Eur Urol 50: 777-785, 2006.
28. Watanabe Y, Usada N, Minami H, Morita T, Tsugane S, Ishikawa R, Kohama K, Tomida Y and Hidaka H: Calvasculin, as a factor affecting the microfilament assemblies in rat fibroblasts transfected by src gene. FEBS Lett 324: 51-55, 1993.
29. Li ZH, Spektor A, Varlamova O and Bresnick AR: Mts1 regulates the assembly of nonmuscle myosin-IIA. Biochemistry 42: 14258-14266, 2003.
30. Kriajevska M, Tarabykina S, Bronstein I, Maitland N, Lomonosov M, Hansen K, Georgiev G and Lukanidin E: Metastasis-associated Mts1 (S100A4) protein modulates protein kinase C phosphorylation of the heavy chain of nonmuscle myosin. J Biol Chem 273: 9852-9856, 1998.
31. Takenaga K, Nakamura Y, Sakiyama S, Hasegawa Y, Sato K and Endo H: Binding of pEL98 protein, an S100-related calcium-binding protein, to nonmuscle tropomyosin. J Cell Biol 124: 757-768, 1994.
32. Grigorian M, Andresen S, Tulchinsky E, Kriajevska M, Carlberg C, Kruse C, Cohn M, Ambartsumian N, Christensen A, Selivanova G et al: Tumor suppressor p53 protein is a new target for the metastasis-associated Mts1/S100A4 protein: functional consequences of their interaction. J Biol Chem 276: 22699-22708, 2001.
33. Chen H, Fernig DG, Rudland PS, Sparks A, Wilkinson MC and Barraclough R: Binding to intracellular targets of the metastasis-inducing protein, S100A4 (p9Ka). Biochem Biophys Res Commun 286: 1212-1217, 2001.
34. Wang G, Zhang S, Fernig DG, Martin-Fernandez M, Rudland PS and Barraclough R: Mutually antagonistic actions of S100A4 and S100A1 on normal and metastatic phenotypes. Oncogene 24: 1445-1454, 2005.
35. Ji J, Zhao L, Wang X, Zhou C, Ding F, Su L, Zhang C, Mao X, Wu M and Liu Z: Differential expression of S100 gene family in human esophageal squamous cell carcinoma. J Cancer Res Clin Oncol 130: 480-486, 2004.
36. Tolson JP, Flad T, Gnau V, Dihazi H, Hennenlotter J, Beck A, Mueller GA Kuczyk M and Mueller CA: Differential detection of S100A8 in transitional cell carcinoma of the bladder by pair wise tissue proteomic and immunohistochemical analysis. Proteomics 6: 697-708, 2006.
37. Hiratsuka S, Watanabe A, Aburatani H and Maru Y: Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis. Nat Cell Biol 8: 1369-1375, 2006.
38. Hermani A De Servi B, Medunjanin S, Tessier PA and Mayer D: S100A8 and S100A9 activate MAP kinase and NF-kappaB signaling pathways and trigger translocation of RAGE in human prostate cancer cells. Exp Cell Res 312: 184-197, 2006.
39. Sakaguchi M, Miyazaki M, Inoue Y, Tsuji T, Kouchi H, Tanaka T, Yamada H and Namba M: Relationship between contact inhibition and intranuclear S100C of normal human fibroblasts. J Cell Biol 149: 1193-1206, 2000.
40. Sakaguchi M, Tsuji T, Inoue Y, Miyazaki M, Namba M, Yamada H and Tanaka T: Loss of nuclear localization of the S100C protein in immortalized human fibroblasts. Radia Res 155: 208-214, 2001.
41. Ohuchida K, Mizumoto K, Ohhashi S, Yamaguchi H, Konomi H, Nagai E, Yamaguchi K, Tsuneyoshi M and Tanaka M: S100A11, a putative tumor suppressor gene, is overexpressed in pancreatic carcinogenesis. Clin Cancer Res 12: 5417-5422, 2006.
42. Rust R, Visser L, van der Leij J, Harms G, Blokzijl T, Deloulme JC, van der Vlies P, Kamps W, Kok K, Lim M et al: High expression of calcium-binding proteins, S100A10, S100A11 and CALM2 in anaplastic large cell lymphoma. Br J Haematol 131: 596-608, 2005.
43. Rehman I, Azzouzi AR, Cross SS, Deloulme JC, Catto JW, Wylde N, Larre S, Champigneuille J and Hamdy FC: Dysregulated expression of S100A11 (calgizzarin) in prostate cancer and precursor lesions. Hum Pathol 35: 1385-1391, 2004.
44. Mori M, Shimada H, Gunji Y, Matsubara H, Hayashi H, Nimura Y, Kato M, Takiguchi M, Ochiai T and Seki N: S100A11 gene identified by in-house cDNA microarray as an accurate predictor of lymph node metastases of gastric cancer. Oncol Rep 11: 1287-1293, 2004.
45. Fukuzawa H, Kiyoshima T, Kobayashi I, Ozeki S and Sakai H: Transcription promoter activity of the human S100A7 gene in oral squamous cell carcinoma cell lines. Biochim Biophys Acta 1759: 171-176, 2006.
46. Brouard MC, Saurat JH, Ghanem G and Siegenthaler G: Urinary excretion of epidermal-type fatty acid-binding protein and S100A7 protein in patients with cutaneous melanoma. Melanoma Res 12: 627-631, 2002.
47. Krop I, Marz A, Carlsson H, Li X, Bloushtain-Qimron N, Hu M, Gelman R, Sabel MS, Schnitt S, Ramaswamy S et al: A putative role for psoriasin in breast tumor progression. Cancer Res 65: 11326-11334, 2005.
48. El-Rifai W, Moskaluk CA Abdrabbo MK, Harper J, Yoshida C, Riggins GJ, Frierson HF Jr and Powell SM: Gastric cancers overexpress S100A calcium-binding proteins. Cancer Res 62: 6823-6826, 2002.
49. Donato R: Functional roles of S100 proteins, calcium-binding proteins of the EF-hand type. Biochim Biophys Acta 1450: 191-231, 1999.
50. Donato R: Intracellular and extracellular roles of S proteins. Microsc Res Tech 60: 540-551, 2003.
51. Millward TA, Heizmann CW, Schafer BW and Hemmings BA: Calcium regulation of Ndr protein kinase mediated by S100 calcium-binding proteins. EMBO J 17: 5913-5922, 1998.
52. Zimmer DB, Cornwall EH, Reynolds PD and Donald CM: S100A1 regulates neurite organization, tubulin levels, and proliferation in PC12 cells. J Biol Chem 273: 4705-4711, 1998.
53. Wicki R, Franz C, Scholl FA, Heizmann CW and Schafer BW: Repression of the candidate tumor suppressor gene S100A2 in breast cancer is mediated by site-specific hypermethylation. Cell Calcium 22: 243-254, 1997.
54. Heighway J, Knapp T, Boyce L, Brennand S, Field JK, Betticher DC, Ratschiller D, Gugger M, Donovan M, Lasek A et al: Expression profiling of primary non-small cell lung cancer for target identification. Oncogene 21: 7749-7763, 2002.
55. Marenholz I, Lovering RC and Heizmann CW: An update of the S100 nomenclature. Biochim Biophys Acta 26: 26, 2006.